PME Symposia
PME Breakfast Symposium (Non-CME)
Thursday, October 17 | 6:45 AM – 7:45 AM
Attention on MASH: The Hepatic Manifestation of the Metabolic Syndrome
Sponsored by Novo Nordisk.
Speaker:
Steven L. Flamm, MD, FAASLD, FACG
PME Lunch Symposium (Non-CME)
Thursday, October 17 | 11:15 AM – 12:15 PM
Perspectives in Hyperglycemia Secondary to Hypercortisolism – A Path to Diagnosis
Sponsored by Corcept Therapeutics.
Speakers:
Davida F. Kruger, MSN, APN-BC,BC-ADM
Jay Shubrook, DO, FAAFP, FACOFP
Alison Gracom, PA-C
Program Description:
Case-based panel discussion on evolving perspectives in endogenous Cushing Syndrome
PME Dinner Symposium (Non-CME)
Thursday, October 17 | 6:00 PM – 7:00 PM
Mounjaro® (tirzepatide) Product Theater
Sponsored by Lilly.
Speaker:
James W. Chu, MD, FACE
Endocrinologist
Program Description:
Join a presentation from one of your peers to learn about Mounjaro, a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults with type 2 diabetes (T2D). This presentation will include a review of clinical efficacy and safety results, and how to get your adult patients with T2D started on Mounjaro. Attendees will have the opportunity to pose questions to the speaker at the end of the session.
Please see the Important Safety Information for Mounjaro, including Boxed Warning about possible thyroid tumors, including thyroid cancer, the Full Prescribing Information, and Medication Guide provided at the product theater.
This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.
PME Breakfast Symposium (Non-CME)
Friday, October 18 | 6:45 AM – 7:45 AM
A Treatment Option for Patients with Heart Failure
Sponsored by AstraZeneca.
SpeakerS:
Suren Sivarajah, MD
Endocrinologist
Justin Fongemie, PharmD, BCCP
Pharmacist
PME Lunch Symposium (Non-CME)
Friday, October 18 | 12:30 PM – 1:30 PM
Overcoming the Hurdles: Address CV Risk and Weight in Appropriate Patients
Sponsored by Novo Nordisk.
Speaker:
Matthew Budoff, MD
Cardiologist
Learning Objectives:
- Recognize obesity as a chronic, progressive disease and explore the relationship between obesity and cardiovascular disease (CVD).Â
- Discuss the need to address cardiovascular (CV) risk and weight in adults with CVD and obesity or overweight.Â
- Analyze the efficacy and safety data from a cardiovascular outcomes trial as well as from relevant chronic weight management trials.
PME Dinner Symposium (Non-CME)
Friday, October 18 | 6:05 PM – 7:05 PM
Product Theater for ZepboundTM(tirzepatide) Injection
Sponsored by Lilly.
Speaker:
Nicole A. Ciffone, MS, ANP-C, AACC, FNLA
Lipid Specialist
Founder/Director, Arizona Center For Advanced Lipidology
Program Description:
- Join a presentation from one of your peers on the efficacy and safety of once-weekly Zepbound, and learn about how to get appropriate patients started on this treatment. Attendees will have the opportunity to pose questions to the speaker at the end of the session. Refreshments will be provided.
- Please see the Important Safety Information for Zepbound, including Boxed Warning about possible thyroid tumors, including thyroid cancer, the full Prescribing Information, and Medication Guide provided at the Product Theater.
- This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.
PME Breakfast Symposium (Non-CME)
Saturday, October 19 | 7:00 AM – 8:00 AM
WAINUA: Overview of a Treatment Option for hATTR-PN
Sponsored by AstraZeneca.
